The cytotoxicity of the (-)- and (+)-isomers and the
quinone metabolite
gossypolone prepared from the naturally occurring polyphenolic dialdehyde
gossypol were compared using two human
melanoma cell lines (SK-mel-19 and SK-mel-28) with a similar growth rate, one melanotic (
melanin content of 69 pg/cell) and one amelanotic (
melanin content of 10 pg/cell). Results from two viability assays (MTT and flow cytometry) showed that the cytotoxicity of racemic
gossypol was identical for both cell lines (50% inhibition of cell growth IC50 = 22 microM).
Gossypolone at equimolar concentrations was inactive in the amelanotic cell line and as potent as racemic
gossypol in the melanotic cell line. (-)-
Gossypol was significantly more active in both cell lines compared with the (+)-isomer. The cytotoxic effect of (-)-
gossypol was both concentration and time dependent. Under serum-free conditions, the cytotoxicity of both enantiomers was increased, suggesting that
serum protein binding may play a role in the differential toxicity of these isomers in vitro. Morphological changes after exposure to (-)-
gossypol included shrinkage and loss of adherence. Cell sensitivity to the (-)-isomer was five-fold greater (IC50 = 4 microM) using a clonogenic assay. At equimolar concentrations, (-)-
gossypol was more cytotoxic to both cell lines than the clinically used drugs
cisplatin,
dacarbazine and
melphalan. The results of this study suggest that (-)-
gossypol may be of potential therapeutic benefit in
melanoma patients.